We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

186 hedge funds and large institutions have $1.48B invested in Dr. Reddy's Laboratories in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 66 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

106% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 17

29% more capital invested

Capital invested by funds: $1.15B → $1.48B (+$337M)

10% more funds holding

Funds holding: 169 → 186 (+17)

0.83% less ownership

Funds ownership: 65.08% → 64.24% (-0.83%)

18% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 66

18% less call options, than puts

Call options by funds: $1.84M | Put options by funds: $2.25M

Holders
186
Holders Change
+17
Holders Change %
+10.06%
% of All Funds
3.75%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
35
Increased
54
Reduced
66
Closed
17
Calls
$1.84M
Puts
$2.25M
Net Calls
-$410K
Net Calls Change
-$787K

Top Buyers

1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$10.9M
2
Morgan Stanley
Morgan Stanley
New York
+$8.12M
3
N
Nuveen
North Carolina
+$7.95M
4
Lazard Asset Management
Lazard Asset Management
New York
+$7.48M
5
State Street
State Street
Massachusetts
+$4.39M

Top Sellers

1
BlackRock
BlackRock
New York
-$9.62M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$8.17M
3
PPA
Parametric Portfolio Associates
Washington
-$6.44M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.28M
5
Goldman Sachs
Goldman Sachs
New York
-$6.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
126
Almanack Investment Partners
Pennsylvania
$309K – – –
Two Sigma Advisers
127
Two Sigma Advisers
New York
$306K -$2.57M -216,000 -91%
AIM
128
Aigen Investment Management
New York
$301K +$258K +21,650 New
PA
129
Parallel Advisors
California
$283K +$5.78K +485 +2%
QWM
130
QP Wealth Management
New Jersey
$277K +$237K +19,895 New
Truist Financial
131
Truist Financial
North Carolina
$275K +$6.73K +565 +3%
Aviva
132
Aviva
United Kingdom
$274K -$61.7K -5,180 -21%
JIC
133
Johnson Investment Counsel
Ohio
$264K – – –
Mercer Global Advisors
134
Mercer Global Advisors
Colorado
$247K +$212K +17,780 New
SW
135
SVB Wealth
Massachusetts
$240K +$206K +17,245 New
QI
136
QS Investors
New York
$236K – – –
SA
137
Shilanski & Associates
Alaska
$224K +$192K +16,110 New
CAM
138
Cresset Asset Management
Illinois
$220K +$188K +15,810 New
AIM
139
ARGA Investment Management
Connecticut
$218K -$363K -30,470 -66%
GC
140
Guggenheim Capital
Illinois
$211K +$181K +15,200 New
WI
141
Wintrust Investments
Illinois
$210K +$180K +15,105 New
FIM
142
Fernwood Investment Management
Massachusetts
$209K +$179K +15,000 New
GC
143
Grace Capital
Massachusetts
$208K – – –
TC
144
TownSquare Capital
Utah
$205K +$177K +14,810 New
LPL Financial
145
LPL Financial
California
$204K +$175K +14,655 New
AIM
146
AIA Investment Management
Singapore
$182K +$156K +13,075 New
CAW
147
Cornerstone Advisors (Washington)
Washington
$173K -$536 -45 -0.4%
BCV
148
Banque Cantonale Vaudoise
Switzerland
$171K +$536 +45 +0.4%
QCG
149
Quadrant Capital Group
Ohio
$163K +$37.8K +3,170 +37%
MIFH
150
Migdal Insurance & Financial Holdings
Israel
$139K – – –
4 5
6
7 8

RDY Hedge Fund Activity: Q3 2020 in Review

186 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2020, worth a combined $1.48B — up 29% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new RDY positions and 17 closed out — a net gain of 18 holders — while 54 added to existing stakes and 66 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $10.9M. The largest seller was BlackRock, cutting an estimated $9.62M.

  • 186 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2020, up from 169 in Q2 2020.
  • Funds reported $1.48B of Dr. Reddy's Laboratories stock for Q3 2020, up 29% quarter-over-quarter.
  • 35 funds opened new Dr. Reddy's Laboratories positions in Q3 2020 and 17 closed out, a net change of +18 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2020 was Bank of Montreal, an estimated $10.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2020 was BlackRock, an estimated $9.62M sold.

Based on aggregated 13F filings for Q3 2020.